Paederia scandens is a
natural medicinal
plant that is widely used for its various pharmacological effects
including antiviral, antitumor, anti-inflammatory, and antibacterial
activities. However, there is no scientific evidence to support its
antidiarrheal effect. In this study, the antidiarrheal activity of P. scandens was evaluated using several validated
models. By using HPLC-ESI-MS in conjunction with a network pharmacology
approach, the possible antidiarrheal mechanisms of P. scandens active fragments were studied, and they
were subsequently verified in a mouse model of diarrhea. Finally,
utilizing molecular docking, active compounds that might have antidiarrheal
properties were hypothesized. The results show that the main antidiarrheal
part of P. scandens has 10 chemical
components in the n-butanol fraction (PSNB). The
key targets of PSNB and diarrhea, EGFR, AKT1, and PIK3CA, were screened
by network pharmacology analysis. And the mechanism of PSNB in the
treatment of diarrhea may be highly related to the EGFR tyrosine kinase
inhibitor resistance and PI3K/AKT signaling pathway. Besides, through
the qRT-PCR and western-blot experiments, it was found that PSNB could
inhibit the gene expression of proinflammatory factors by reducing
the protein expression of AKT1 and PI3K and regulating the NF-κB
signaling pathway in mice. In addition, asperuloside, paederosidic
acid, paederoside, paederosidic acid methyl ester, and 6′-O-E-feruloylmonotropein
have better docking energies than other chemical components in PSNB
with EGFR, AKT1, and PIK3CA. In conclusion, the main antidiarrheal
active site of P. scandens is the n-butanol site. PSNB may exert an antidiarrheal effect by
regulating the PI3K/Akt/NF-κB signaling pathway. Among them,
asperuloside, paederosidic acid, paederoside, paederosidic acid methyl
ester, and 6′-O-E-feruloylmonotropein may be the active ingredients
that exert an antidiarrheal effect.